Learning Objectives:

1. To establish whether treatment with corticosteroid-cyclophosphamide induced remission of nephrotic syndrome in a significantly greater number of patients than treatment with tacrolimus-rituximab, although side-effects were more frequent in the former group.
2. To determine clinical significance of study results.